Pelage Pharmaceuticals is pioneering the first regenerative approach to hair loss, grounded in stem cell biology
Pelage Pharmaceuticals is pioneering the first regenerative approach to hair loss, grounded in stem cell biology. The company is developing PP405, a non-invasive topical therapy designed to reactivate dormant hair follicle stem cells and restore hair growth.